Leukemia is one of the most common cancers of childhood. So, as childhood cancer awareness month comes to a close on this almost final day of September, we wanted to take a moment to help explain a groundbreaking new FDA treatment – CAR-T cells – that offers hope to children with a form of relapsed pediatric leukemia called acute lymphoblastic leukemia, or ALL.
What are CAR-T cells and why do they hold so much promise? Two of UW Carbone Cancer Center’s experts, Peiman Hematti, MD and Christian Capitini, MD, help explain:
Read the full article at: https://uwmadscience.news.wisc.edu/health/driving-the-car-t-toward-better-cancer-treatments/